Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NG2-cells

Financiado

Cerrado

The role of NG2 cells in the neural network in health and disease

Loss of myelin and oligodendrocyte dysfunction is being recognized in many neurodegenerative diseases, such as Multiple Sclerosis, Alzheimer's or Parkinson's disease or Epilepsy, although the mechanisms are not yet understood. Oli... ver más

31/05/2022

265K€

Presupuesto del proyecto: 265K€

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-05-31

MSCA-IF-2018: Individual Fellowships

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

264.67K€ | Lider

UCONN

177.27K€ | Participante

Proyectos interesantes

KON-TIKIGENET

Medical Technol...

Applied Physics

222K€ Cerrado

MOTOGLIA

Medical Technol...

Applied Physics

2M€ Cerrado

SAF2016-75292-R

Medical Technol...

Applied Physics

411K€ Cerrado

SECRETASES & MYELIN

Medical Technol...

Applied Physics

100K€ Cerrado

BFU2016-75207-R

Medical Technol...

Applied Physics

218K€ Cerrado

BFU2017-87843-R

Medical Technol...

Applied Physics

133K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 37 meses Fecha Inicio: 2019-04-05
Fecha Fin: 2022-05-31

Líder del proyecto

EBERHARD KARLS UNIVERSITAET TUEBINGEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 265K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Loss of myelin and oligodendrocyte dysfunction is being recognized in many neurodegenerative diseases, such as Multiple Sclerosis, Alzheimer's or Parkinson's disease or Epilepsy, although the mechanisms are not yet understood. Oligodendrocytes are generated from NG2 cells, a glial cell population that covers the entire parenchyma of the central nervous system. The multitude of disorders involving oligodendrocyte pathologies in grey and white matter underscores the importance to understand how oligodendrocyte differentiation and myelination are regulated, and the role of NG2 cells therein. The highest density of NG2 cells can be found during the first postnatal weeks, when they differentiate into mature oligodendrocytes ensheathing axons with myelin. NG2 cells retain the capacity for self-renewal throughout life, rendering them a huge regenerative potential in the adult brain. It is still unknown whether all NG2 cells have the same potential to generate oligodendrocytes or whether a subpopulation of them becomes permanent NG2 cells. Neurons form synaptic contacts onto NG2 cells and depolarize them, in order to regulate myelination. Considering the finding, that processes of NG2 glia contact neurons at the node of Ranvier, it could be possible that NG2 cells in turn are able to modulate neuronal activity. To address these questions, this project is designed to investigate how altered neuronal excitability affects the structural and functional relationship between neurons and NG2 cells and how these changes impact the neural network. Using a combination of several cutting-edge techniques, the details of the morphological contact formation as well as the physiological function of these contacts in vivo in models of enhanced neuronal activity will be assessed. The results will be a major contribution to understanding the role of NG2 cells in the neural network in healthy organisms as well as in the numerous diseases where oligodendrocytes are affected.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores